
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1037 | 1037 | 1100 | 1231 | 1781 | 1796 |
Fund Return | 3.74% | 3.74% | 9.98% | 7.19% | 12.24% | 6.03% |
Place in category | 314 | 314 | 239 | 168 | 138 | 103 |
% in Category | 55 | 55 | 43 | 34 | 31 | 31 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Royal London FTSE 350 Tracker Z Fun | 5.17B | 3.75 | 7.05 | 5.98 | ||
Royal London European Growth Fund C | 2.45B | 6.84 | 6.84 | 7.44 | ||
Royal London UK Equity Income A | 1.15B | 5.12 | 8.81 | 5.78 | ||
Royal London UK Equity Income Fund | 1.15B | 5.19 | 9.30 | 6.39 | ||
Royal London UK Equity Income M GBP | 1.15B | 5.18 | 9.22 | 6.28 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Index Unit Trust Accumulation | 14.12B | 4.47 | 6.97 | 6.08 | ||
All Share Index Unit Trust Income | 14.12B | 9.33 | 5.75 | 6.09 | ||
VG UK Plus GBP Accumulation | 14.12B | 9.34 | 5.76 | 6.12 | ||
VG UK Institutional Plus GBP Income | 14.12B | 9.34 | 5.75 | 6.11 | ||
UK Equity Tracker Fund D Acc | 12.01B | 3.49 | 6.88 | 6.07 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
AstraZeneca | GB0009895292 | 6.64 | 10,320.0 | +3.12% | |
Shell | GB00BP6MXD84 | 6.30 | 27.51 | +2.73% | |
HSBC | GB0005405286 | 6.03 | 770.90 | +3.69% | |
ICF FTSE 100 IDX FUT MAR25 | GB00KNSR9V84 | 4.58 | - | - | |
Unilever | GB00B10RZP78 | 4.49 | 54.54 | +1.19% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Buy |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review